Northern Trust Corp Curis Inc Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.57 - $0.99 $16,600 - $28,832
-29,124 Reduced 15.98%
153,136 $127,000
Q1 2023

May 15, 2023
BUY
$0.51 - $0.78 $9,334 - $14,276
18,303 Added 11.16%
182,260 $109,000
Q2 2022

Aug 12, 2022
SELL
$0.71 - $2.43 $453,690 - $1.55 Million
-639,001 Reduced 79.58%
163,957 $161,000
Q1 2022

May 13, 2022
SELL
$2.31 - $5.13 $83,199 - $184,767
-36,017 Reduced 4.29%
802,958 $1.91 Million
Q4 2021

Feb 08, 2022
SELL
$4.45 - $8.09 $608,808 - $1.11 Million
-136,811 Reduced 14.02%
838,975 $3.99 Million
Q3 2021

Nov 15, 2021
SELL
$6.94 - $8.85 $236,938 - $302,147
-34,141 Reduced 3.38%
975,786 $7.64 Million
Q2 2021

Aug 13, 2021
BUY
$7.45 - $16.27 $6.41 Million - $14 Million
859,880 Added 573.07%
1,009,927 $8.15 Million
Q1 2021

May 12, 2021
BUY
$8.78 - $12.8 $427,085 - $622,630
48,643 Added 47.97%
150,047 $1.7 Million
Q4 2020

Feb 11, 2021
BUY
$1.08 - $8.2 $23,169 - $175,914
21,453 Added 26.83%
101,404 $830,000
Q3 2020

Nov 16, 2020
BUY
$0.95 - $1.42 $19,128 - $28,591
20,135 Added 33.66%
79,951 $94,000
Q2 2020

Aug 14, 2020
BUY
$0.63 - $1.7 $730 - $1,970
1,159 Added 1.98%
59,816 $73,000
Q1 2020

May 14, 2020
BUY
$0.67 - $1.85 $67 - $185
100 Added 0.17%
58,657 $42,000
Q4 2019

Feb 14, 2020
SELL
$1.36 - $2.44 $3,986 - $7,151
-2,931 Reduced 4.77%
58,557 $99,000
Q3 2019

Nov 13, 2019
SELL
$1.74 - $2.83 $1,218 - $1,981
-700 Reduced 1.13%
61,488 $138,000
Q2 2019

Aug 13, 2019
SELL
$1.36 - $2.35 $5,440 - $9,400
-4,000 Reduced 6.04%
62,188 $116,000
Q1 2019

May 13, 2019
BUY
$0.78 - $2.01 $3,120 - $8,039
4,000 Added 6.43%
66,188 $132,000
Q4 2018

Feb 12, 2019
SELL
$0.62 - $2.25 $264 - $958
-426 Reduced 0.68%
62,188 $43,000
Q3 2018

Nov 14, 2018
SELL
$1.38 - $1.94 $35 - $50
-26 Reduced 0.04%
62,614 $112,000
Q2 2018

Aug 14, 2018
BUY
$1.73 - $3.35 $108,367 - $209,844
62,640 New
62,640 $109,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email